Absence of Wip1 partially rescues Atm deficiency phenotypes in mice

Y Darlington1, T-A Nguyen, S-H Moon

  • 1Interdepartmental Graduate Program in Cell and Molecular Biology, Houston, Baylor College of Medicine, Houston, TX 77030, USA.

Oncogene
|July 19, 2011
PubMed

Insights

Inhibiting WIP1 phosphatase may help treat cancer and A-T. Removing WIP1 in mice lacking ATM protected against lymphoma and extended lifespan, indicating enhanced DNA damage responses.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Wild-type p53-induced phosphatase 1 (WIP1) is a serine/threonine phosphatase.
  • WIP1 dephosphorylates proteins in the ataxia telangiectasia mutated (ATM)-initiated DNA damage response pathway.
  • WIP1 may restore cellular homeostasis post-DNA repair.

Purpose of the Study:

  • To investigate the effects of WIP1 on ATM signaling.
  • To characterize the phenotypes of Atm-deficient and Wip1-deficient double knockout mice.
  • To test the hypothesis that Wip1 deficiency could rescue Atm deficiency phenotypes.

Main Methods:

  • Crossed Atm-deficient mice with Wip1-deficient mice.
  • Characterized phenotypes of double knockout progeny.
  • Analyzed lymphoma development, lifespan, DNA damage markers (p53, H2AX, p21), chromosomal instability, and gametogenesis.

Main Results:

  • Double knockout mice showed protection from lymphoma and extended lifespan compared to Atm null mice.
  • Enhanced p53 and H2AX phosphorylation and increased p21 expression were observed in double knockout mice.
  • Reduced chromosomal instability and partial rescue from gametogenesis defects were noted in double knockout mice.

Conclusions:

  • WIP1 deficiency can rescue ATM deficiency phenotypes.
  • Inhibition of WIP1 may be a viable strategy for cancer therapy, particularly for A-T patients.
  • WIP1 plays a significant role in regulating the DNA damage response pathway.

Related Concept Videos